Cansortium Inc. (OTCMKTS:CNTMF – Get Free Report) was the recipient of a large decrease in short interest during the month of August. As of August 31st, there was short interest totaling 2,951 shares, a decrease of 92.6% from the August 15th total of 39,903 shares. Based on an average daily trading volume, of 363,101 shares, the short-interest ratio is presently 0.0 days.
Cansortium Stock Performance
Shares of OTCMKTS CNTMF traded up $0.00 during mid-day trading on Thursday, reaching $0.02. 306,537 shares of the company were exchanged, compared to its average volume of 388,522. Cansortium has a 52 week low of $0.00 and a 52 week high of $0.08. The company’s 50 day moving average price is $0.02 and its 200 day moving average price is $0.03.
Cansortium Company Profile
Cansortium, Inc (OTCMKTS:CNTMF) is a vertically integrated cannabis company engaged in the cultivation, manufacturing, distribution and retail of medical cannabis products in the United States. The company’s operations span from seed to sale, with dedicated cultivation facilities, extraction labs and a network of dispensaries serving registered patients.
Cansortium holds licenses and operates in multiple jurisdictions, including Florida, Pennsylvania, Louisiana, Texas and Puerto Rico. Its product portfolio encompasses cannabis flower, pre-rolls, concentrates, vape cartridges, oils, edibles and topicals, offered under brands such as The+Source, Chroma and Campfire, alongside its private-label formulations.
Founded in 2017 and headquartered in Miami, Cansortium began dispensary operations in Florida in 2018 and has since expanded its footprint into new markets.
Featured Stories
- Five stocks we like better than Cansortium
- AeroVironment’s Record Backlog and Earnings Beat Fuel Recovery Case
- Corning Just Locked In a Massive Verizon Fiber Deal as AI Infrastructure Expands
- 3 Under-$20 Stocks Tied to the Future of U.S. Energy and Materials
- Uncle Sam’s Quantum Leap: Feds Fund a $300M Quantum Supercycle
Receive News & Ratings for Cansortium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cansortium and related companies with MarketBeat.com's FREE daily email newsletter.
